TUDOR INVESTMENT CORP ET AL

Position in RGNX — REGENXBIO Inc.

CIK 923093 STAMFORD, CT

Position in RGNX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$285,770

+$82,053 QoQ

Shares Held

23,854

-1.9% QoQ

Ownership

0.036%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#89

of 163 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 50% Shared 50% None 0%

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names. RGNX ranks #90 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	943,287	$66,643,226
2	RPRX	Royalty Pharma plc	610,736	$34,243,967
3	XENE	Xenon Pharmaceuticals Inc.	545,387	$32,919,559
4	ABVX	Abivax S.A.	187,335	$24,964,262
5	INSM	INSMED Inc	195,391	$20,832,588
6	MLYS	Mineralys Therapeutics, Inc.	738,370	$19,921,222
7	ABCL	AbCellera Biologics Inc.	2,063,191	$16,196,049
8	QURE	uniQure N.V.	328,889	$15,148,627

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$285,770	23,854	-1.9%	Shares	Defined	2026-08-14
2026-03-31	$203,717	24,310	0.0%	Shares	Defined	2026-05-15
2025-12-31	$350,064	24,310	+0.8%	Shares	Defined	2026-02-17
2025-03-31	$172,479	24,123	-2.8%	Shares	Defined	2025-05-15
2024-09-30	$260,309	24,815	-6.0%	Shares	Defined	2024-11-14
2024-06-30	$308,961	26,407	+16.4%	Shares	Defined	2024-08-14
2023-09-30	$373,543	22,694	+73.8%	Shares	Defined	2023-11-15
2023-06-30	$260,969	13,055	-48.7%	Shares	Defined	2023-08-14
2023-03-31	$481,297	25,452	+129.1%	Shares	Defined	2023-05-15
2022-12-31	$251,974	11,110	-20.1%	Shares	Defined	2023-02-14
2022-09-30	$367,403	13,901	+12.9%	Shares	Defined	2022-11-14
2022-03-31	$408,801	12,317	-3.5%	Shares	Defined	2022-05-16
2021-03-31	$435,516	12,768	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.